My Treatment Approach: Relapsed/Refractory Follicular Lymphoma

Brian Hill, MD, PhD and Lori Leslie, MD, discuss their respective treatment approaches to relapsed/refractory follicular lymphoma (R/R FL), sharing patient cases, reviewing treatment options for patients with the disease, and providing clinical advice for community-based oncologists.

EP. 1: Follicular Lymphoma Background and Introduction to a Patient Case

October 27th 2022

Brian T. Hill, MD, PhD briefly reviews the diagnosis and staging of FL, typical prognoses for patients with the disease, and begins to outline a patient case of R/R FL.

EP. 2: First-, Second-, and Third-Line Treatment Selection for a FL Patient Case

October 27th 2022

Dr Hill continues his discussion of the case, outlining the first-, second, and third-line treatment strategies employed for this particular patient.

EP. 3: Typical Treatment Responses in Patients with FL and Incidence of Relapsed or Refractory Disease

November 3rd 2022

Insights concerning typical treatment responses experienced by patients with FL, clinical factors that may be predictive of response, and the incidence of relapsed or refractory disease.

EP. 4: Considerations for Treatment Selection in the Third-Line R/R FL Setting

November 3rd 2022

Dr Hill shares how he would have handled the patient case and discusses factors that contribute to treatment selection among third-line therapies for patients with R/R FL, including axicabtagene ciloleucel and other CAR T-cell therapies.

EP. 5: CAR T-cell Options for Patients with R/R FL

November 10th 2022

A focused discussion on available CAR T-cell therapies for patients with R/R FL, supporting efficacy data, and how these therapies have impacted the field.

EP. 6: Closing Remarks on Unmet Needs in R/R FL

November 10th 2022

Dr Hill closes by discussing current unmet needs in the R/R FL landscape and giving practical advice to providers caring for patients with FL.

EP. 7: Overview on Follicular Lymphoma and A Patient Case of Relapsed/Refractory Disease

November 23rd 2022

Expert hematologist-oncologist Lori Leslie, MD, provides insight to the incidence and prognosis of follicular lymphoma, highlighting a patient case of refractory disease.

EP. 8: Assessing Response to Therapy and High-Risk Disease in Follicular Lymphoma

November 23rd 2022

An expert’s perspective on assessing response to therapy in follicular lymphoma and the parameters used to identify high-risk disease.

EP. 9: Relapsed/Refractory Follicular Lymphoma: Sequencing Through Multiple Lines of Therapy

November 30th 2022

Key opinion leader Lori Leslie, MD, sheds light on the optimal sequencing of therapy throughout multiple lines of follicular lymphoma.

EP. 10: Novel Third-Line Therapies for Relapsed/Refractory Follicular Lymphoma

November 30th 2022

A comprehensive overview of the third-line treatment armamentarium for patients with relapsed/refractory follicular lymphoma.